Structure-Based Design of Selective Janus Kinase 2 Imidazo[4,5-d]pyrrolo[2,3-b]pyridine Inhibitors

[Image: see text] Early hit to lead work on a pyrrolopyridine chemotype provided access to compounds with biochemical and cellular potency against Janus kinase 2 (JAK2). Structure-based drug design along the extended hinge region of JAK2 led to the identification of an important H-bond interaction w...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :ACS Med Chem Lett
Главные авторы: Hart, Amy C., Schroeder, Gretchen M., Wan, Honghe, Grebinski, James, Inghrim, Jennifer, Kempson, James, Guo, Junqing, Pitts, William J., Tokarski, John S., Sack, John S., Khan, Javed A., Lippy, Jonathan, Lorenzi, Matthew V., You, Dan, McDevitt, Theresa, Vuppugalla, Ragini, Zhang, Yueping, Lombardo, Louis J., Trainor, George L., Purandare, Ashok V.
Формат: Artigo
Язык:Inglês
Опубликовано: American Chemical Society 2015
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC4538451/
https://ncbi.nlm.nih.gov/pubmed/26288682
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/acsmedchemlett.5b00225
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы